Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$1.76, OUCH.... Oh Chucky, not in front of the kids. Another company under leadership accompanied by the proverbial falling knife.
Come one, come all. See oddities from the far reaches of the world. Behold, the stock that never goes up. Stare in awe at its hideousness. No flash photography, please.
Like sitting patiently for hours, waiting for your appointment with a proctologist named Dr. Hook.
Like being put in leg shackles, and forced to play naked Twister, with ugliest women in the world.
Having a kidney stone lodged halfway down your pecker after taking a boner pill and realizing your money is tied up here (RXMD) and your health insurance is in the "Donut Hole" period.
Being a RXMD shareholder is like being a monk in a monastery. Years of silence and a headmaster who could care less about paying the long term residents !!
perfect analogy.
Spot on. Cinderella in the form of a publicly traded company.
Thing is no one knows about Progressive Care.
Who told you that? They just bought another company. Why waste their time and energy on that if it’s all about RX??
Nothing makes sense around here anymore.
Yup, people dont like good company bad stock. rxmd should hire a speaker talk things up as soon as possible.
Was that from Glickman or the filing?
If any of you talk to Glickman, suggest they pay him to write fluff PRs for them. They need to generate interest. A PR every one to two weeks hinting at a bright future would help a lot.
$RXMD
The red tape and bureaucracy in China is bogging down their goals and contracts. They hoped to be alot further along by now.
JS - We need some sort of catalyst to bring buyers here. No one knows about RXMD. Managemnt needs to get the word out.
We are about 20 days from Q results being released which should be great, got to think that shares rise as we get closer to results.
Now what ? quiet period again ???
Do they use satellites to broadcast advertisements for Tmall boner pills to Chinese citizens? Whats the play?
I can answer that!!! NOPE!!!
Do you think they will ditch the satellite biz despite their recent acquisition?
NextPlat satellite biz is losing money. After merger, if they can get rid of that part and show huge profit from Progressive Care, and possibly with another major M/A in healthcare, then this will get some serious attention on Naz.
Take a bit of solace in the fact that companies keep cash on hand for reasons like acquisitions. One big purchase of a solid company would send the stock parabolic IMO. Goodnight and good luck.
I’m tired of hearing about how undervalued we are. 26M in the bank hasn’t made one damn difference. I hope I’m wrong but if feels like we’re all screwed. Tight lipped Charles if stealing our shares come hell or high water. God help us all and his soul if that’s the case. Good luck and good night.
It just feels like this will just keep going lower and lower and it’s inevitable Charles will find a way to strip us all of our investments. Somehow a RS will screw us and benefit him. Then and only then will he grow the company after he fucked all of us. The plans have been laid out. Why are they still so quiet???
Ok. Thank you.
It certainly makes sense to have same audit firms moving forward and is likely the main driver, but my head canon is this is a fallout from the late filing too. Both companies got screwed because of it.
Cabin, JMO but I don't think an RS is in the cards for $RXMD, there's no point. $NXPL though may have one. They are getting close to the dollar limit to stay on NASDAQ. They have a lot of time, though, before they would be forced to have one. Well past November.
$RXMD
With the new merger deal is a reverse split an option? The price just keeps sinking lower. if a RS is an option then the reality is it’s coming imo.
Effective date was April 19, 2024.
Or the date it was approved?
Just thinking out loud.
Does it have a date when the board voted on it?
Also makes sense regarding the recent late filing. I think we now know who dropped the ball.
$RXMD
Driving to job site. The 17th maybe?
Thanks, this makes perfect sense, part of saving money.
“We have engaged RBSM LLP (“RBSM”) as our independent registered public accounting firm, effective April 19, 2024. The decision to engage RBSM as our independent registered public accounting firm was approved by the Board. RBSM is the independent registered public accounting firm of our parent company NextPlat Corp (“NXPL”).”
Not sure if anyone saw the 8k regarding termination of our accounting firm.
True. Their merger will see shares north of $10.
Thought it up 200% more already, so sold all and wait for pps cool down a little bit, but it wasnt, .... so end up buy back higher. Hopefully tomorrow $3 to 4.
Wow , you do good. Long ago i got in was $0.80s, then 0.50s , never make $, i was lucky sold them all @ $1.10s, then bought again at higher price because feel pps may go much higher. Anyway it is better than here waiting for news boringly.
Probably because it will be around $5-$7 by week's end.
Why did you wait until it ran up over $2 dollars to plug it
Loving my 2800 shares there.
Wished I had loaded up when I bought it at .42
Charles Fernandez
Yup stuck … just don’t get if we are soooo crazy undervalued why isn’t a single person buying …
Followers
|
746
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
194275
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |